TrialJournal of gynecologic oncology2022

Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial.

Jung-Yun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.